Ocugen (OCGN) Return on Invested Capital (2021 - 2022)
Ocugen (OCGN) reported Return on Invested Capital of 0.01% for Q4 2022, down 1.0% on a YoY basis from 0.01% in Q4 2021, and down 32.54% quarter-over-quarter from 0.01% in Q3 2022.
Ocugen (OCGN) Return on Invested Capital (2021 - 2022) Analysis & Trends
Ocugen has reported Return on Invested Capital for 2 years, with the latest figure at 0.01% in Q4 2022.
- For the quarter ending Q4 2022, Return on Invested Capital fell 1.0% year-over-year to 0.01%; the trailing twelve-month figure through Dec 2022 stood at 0.01% (down 1.0% YoY), and the FY2021 full-year result was 0.01%, changed N/A from the prior year.
- Return on Invested Capital for Q4 2022 stood at 0.01%, down from 0.01% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.01% in Q4 2021, with the low at 0.01% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.01% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -0.01% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |